十价肺炎球菌结合疫苗对冰岛三岁以下儿童住院的影响
冰岛2011年将十价肺炎球菌结合疫苗(PHiD-CV)纳入国家免疫规划,本研究随访2005-2015年出生队列至3岁,评估该疫苗对儿童呼吸道感染及侵袭性疾病住院的影响。结果显示,肺炎住院减少20%(HR 0.80,95%CI:0.67-0.95),培养确诊侵袭性肺炎球菌病住院减少93%(HR 0.07,95%CI:0.01-0.50),疫苗覆盖型别侵袭性肺炎球菌病住院未观察到;但下呼吸道感染住院增加32%(HR 1.32,95%CI:1.14-1.53),中耳炎住院减少但与疫苗引入时间不重合。
要点
- 肺炎住院减少20%(HR 0.80,95%CI:0.67-0.95),培养确诊侵袭性肺炎球菌病住院减少93%(HR 0.07,95%CI:0.01-0.50)。
- 疫苗覆盖型别侵袭性肺炎球菌病住院在疫苗 eligible 队列中未观察到。
- 下呼吸道感染住院增加32%(HR 1.32,95%CI:1.14-1.53),上呼吸道感染住院亦增加。
核心结论
- 引入PHiD-CV后,冰岛儿童肺炎住院和培养确诊侵袭性肺炎球菌病住院减少,但其他下呼吸道感染和上呼吸道感染住院增加。
研究设计与样本
- 研究随访2005-2015年出生队列至3岁,记录侵袭性肺炎球菌病、脑膜炎、脓毒症、肺炎和中耳炎住院,以上下呼吸道感染住院为对照。
- 2005-2010年出生队列定义为疫苗非 eligible 队列(VNEC),2011-2015年出生队列定义为疫苗 eligible 队列(VEC)。
- 共随访51,264名儿童,累计142,315人年,研究诊断相关住院1,703例。
- 计算发病率(IR)和发病率比(IRR),并采用Cox回归估计住院风险比(HR)。
主要发现
- 肺炎住院减少20%(HR 0.80,95%CI:0.67-0.95)。
- 下呼吸道感染住院增加32%(HR 1.32,95%CI:1.14-1.53)。
- 培养确诊侵袭性肺炎球菌病住院减少93%(HR 0.07,95%CI:0.01-0.50)。
- 疫苗 eligible 队列中未观察到疫苗覆盖型别肺炎球菌所致的侵袭性肺炎球菌病住院。
- 脑膜炎和脓毒症住院无变化;中耳炎住院减少,但与PHiD-CV引入时间不重合。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Pneumococcus is an important respiratory pathogen. The 10-valent pneumococcal vaccine (PHiD-CV) was introduced into the Icelandic vaccination programme in 2011. The aim was to estimate the impact of PHiD-CV on paediatric hospitalisations for respiratory tract infections and invasive disease. METHODS: The 2005-2015 birth-cohorts were followed until three years of age and hospitalisations were recorded for invasive pneumococcal disease (IPD), meningitis, sepsis, pneumonia and otitis media. Hospitalisations for upper- and lower respiratory tract infections (URTI, LRTI) were used as comparators. The 2005-2010 birth-cohorts were defined as vaccine non-eligible cohorts (VNEC) and 2011-2015 birth-cohorts as vaccine eligible cohorts (VEC). Incidence rates (IR) were estimated for diagnoses, birth-cohorts and age groups, and incidence rate ratios (IRR) between VNEC and VEC were calculated assuming Poisson variance. Cox regression was used to estimate the hazard ratio (HR) of hospitalisation between VNEC and VEC. RESULTS: 51,264 children were followed for 142,315 person-years, accumulating 1,703 hospitalisations for the respective study diagnoses. Hospitalisations for pneumonia decreased by 20% (HR 0.80, 95%CI:0.67-0.95) despite a 32% increase in admissions for LRTI (HR 1.32, 95%CI:1.14-1.53). Hospital admissions for culture-confirmed IPD decreased by 93% (HR 0.07, 95%CI:0.01-0.50) and no hospitalisations for IPD with vaccine-type pneumococci were observed in the VEC. Hospitalisations for meningitis and sepsis did not change. A decrease in hospital admissions for otitis media was observed, but did not coincide with PHiD-CV introduction. CONCLUSION: Following the introduction of PHiD-CV in Iceland, hospitalisations for pneumonia and culture confirmed IPD decreased. Admissions for other LRTIs and URTIs increased during this period.
引用
- Sigurdsson S, Eythorsson E, Erlendsdóttir H, et al. Impact of the 10-valent pneumococcal conjugate vaccine on hospital admissions in children under three years of age in Iceland. Vaccine. 2020. PMID: 32063434. doi:10.1016/j.vaccine.2020.01.094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。